Inferra AI / Company / HCA
HCA Healthcare
HCA · Health Care
Last earnings Oct 27, 2026
Key results
Revenuequarter
9.6 percent
Key third quarter metrics (all percentage changes compare 3Q 2025 to 3Q 2024 unless otherwise noted): • Revenues increased 9.6 percent to $19.161 billion • Net income attributable to HCA Healthcare, Inc.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
EPSquarter
42.6 percent
Diluted earnings per share increased 42.6 percent to $6.96 per diluted share, and diluted earnings per share, as adjusted, increased 42.0 percent to $6.96 per diluted share •
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Revenues in the third quarter of 2025 totaled $19.161 billion, compared to $17.487 billion in the third quarter of 2024.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
1 During the third quarter of 2024, the Company incurred additional expenses and experienced loss of revenues estimated at $50 million, or $0.15 per diluted share, associated with Hurricane Helene’s impact on certain facilities located in Florida, Georgia and North Carolina.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Same facility revenue per equivalent admission increased 6.6 percent in the third quarter of 2025, compared to the third quarter of 2024.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Net incomequarter
20.2 %
, as adjusted (a) 1,644 1,273 4,909 4,162 Depreciation and amortization 889 842 2,612 2,456 Interest expense 561 515 1,676 1,533 Provision for income taxes 516 425 1,542 1,370 Net income attributable to noncontrolling interests 260 212 713 649 Adjusted EBITDA (a) 3,870 $ 3,267 $ 11,452 $ 10,170 Adjusted EBITDA margin (a) 20.2 % 18.7 % 20.4 % 19.4 % Diluted earnings per share: Net income attributable to HCA Healthcare, Inc.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
AI analysis
Q3 2025 · reported Oct 24, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Headline figures
| Metric | Q3 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Revenue | 9.6 percent | — | — |
| EPS | 42.6 percent | — | — |
| Net income | 20.2 % | — | — |
Guidance · company-stated
Direction: Raised
“htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports THIRD quarter 2025 results RAISES 2025 Guidance Nashville, Tenn.”
Classified from the release's primary full-year outlook statement.
Capital allocation
’s balance sheet reflected cash and cash equivalents of $997 million, total debt of $44.511 billion, and total assets of $59.747 billion.
Event summary
Results for the third quarter of 2025 include losses on sales of facilities of $2 million, compared to losses on sales of facilities of $4 million, or $0.02 per diluted share, in the third quarter of 2024
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Raised
Company outlook — Raised (“RAISES”)
“htm EX-99.1 EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE INVESTOR CONTACT: MEDIA CONTACT: Frank Morgan Harlow Sumerford 615-344-2688 615-344-1851 HCA Healthcare reports THIRD quarter 2025 results RAISES 2025 Guidance Nashville, Tenn.”
Classified from the release's primary full-year outlook statement.
Capital allocation
’s balance sheet reflected cash and cash equivalents of $997 million, total debt of $44.511 billion, and total assets of $59.747 billion.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
During the third quarter of 2025, capital expenditures totaled $1.288 billion, excluding acquisitions.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
During the third quarter of 2025, the Company repurchased 6.514 million shares of its common stock at a cost of $2.498 billion.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
The Company had $3.256 billion remaining under its repurchase authorization as of September 30, 2025.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
As of September 30, 2025, the Company had $6.076 billion of availability under its credit facility (after giving effect to letters of credit and amounts reserved to backstop its commercial paper program).
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Dividend HCA today announced that its Board of Directors declared a quarterly cash dividend of $0.72 per share on the Company’s common stock.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Strategy & priorities
Forward-looking statements can be identified by the use of words like “may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,” “plan,” “initiative” or “continue.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
federal, state, or foreign tax laws, interpretations of tax laws by taxing authorities, other standard setting bodies or judicial decisions, (25) the results of our efforts to use technology and resilience initiatives, including artificial intelligence and machine learning, to drive efficiencies, better outcomes and an enhanced patient experience, (26) changes to, and the timing and amount of future approvals (if any) of, state Medicaid directed and supplemental payments and (27) other risk factors described in our annual report on Form 10-K for the year ended December 31, 2024 and our other filings with the Securities and Exchange Commission.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Forward-looking statements include statements regarding expected capital expenditures, expected dividends, expected share repurchases, expected net claim payments, expected inflationary pressures, expected labor costs and all other statements that do not relate solely to historical or current facts, and can be identified by the use of words like may, believe, will, expect, project, estimate, anticipate, plan, initiative or continue.
SEC original ↗HCA Healthcare — 10-Q Quarterly report10-QJul 28, 2026
Risks & headwinds
The Company’s guidance contains a number of assumptions, including, among others, the Company’s current expectations regarding volume growth coupled with an anticipated mostly stable operating environment, payer mix, the ongoing impacts of the two major 2024 hurricanes, the impact of current and future health care public policy developments, as well as general business or economic conditions, including inflation, and the impact of trade policies, including tariffs, and excludes the impact of items such as, but not limited to, gains or losses on sales of facilities, losses on retirement of debt, legal claims costs and impairment of long-lived assets.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
The Company’s guidance is based on current plans and expectations and are subject to a number of known and unknown uncertainties and risks, including those set forth below in the Company’s “Forward-Looking Statements.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
3 Forward-Looking Statements This press release contains forward-looking statements within the meaning of the federal securities laws, which involve risks and uncertainties.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
” These forward-looking statements are based on our current plans and expectations and are subject to a number of known and unknown uncertainties and risks, many of which are beyond our control, which could significantly affect current plans and expectations and our future financial position and results of operations.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
In light of the significant uncertainties inherent in the forward-looking statements contained herein, readers should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
$ 27.00 $ 28.00 Shares used in computing diluted earnings per share (millions) 240.000 240.000 The Company's forecasted guidance is based on current plans and expectations and is subject to a number of known and unknown uncertainties and risks.
SEC original ↗HCA Healthcare — Earnings release (8-K exhibit)EX-99Oct 24, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
61 documents- Q3 2026
- 10-QHCA
Oct 29, 2026
- 8-KHCA
Oct 27, 2026
- Q2 2026
- 8-KHCA
Jul 29, 2026
- 10-QHCA
Jul 28, 2026
- 8-KHCA
Jul 24, 2026
- 8-KHCA
Jul 14, 2026
- Q1 2026
- 8-KHCA
Jun 18, 2026
- 8-KHCA
Apr 30, 2026
- 10-QHCA
Apr 29, 2026
- 8-KHCA
Apr 28, 2026
- 8-KHCA
Apr 27, 2026
- 8-KHCA
Apr 24, 2026
- Q4 2025
- 8-KHCA
Feb 25, 2026
- 10-KHCA
Feb 10, 2026
- 8-KHCA
Jan 27, 2026
- Q3 2025
- 8-KHCA
Oct 31, 2025
- 10-QHCA
Oct 30, 2025
- 8-KHCA
Oct 27, 2025
- 8-KHCA
Oct 24, 2025
- Q2 2025
- 10-QHCA
Aug 4, 2025
- 8-KHCA
Jul 25, 2025
- 8-KHCA
Jul 11, 2025
- Q1 2025
- 8-KHCA
Jun 10, 2025
- 10-QHCA
May 1, 2025
- 8-KHCA
Apr 29, 2025
- 8-KHCA
Apr 25, 2025
- Q4 2024
- 8-KHCA
Feb 24, 2025
- 8-KHCA
Feb 21, 2025
- 8-KHCA
Feb 20, 2025
- 8-KHCA
Feb 18, 2025
- 10-KHCA
Feb 14, 2025
- 8-KHCA
Jan 24, 2025
- Q3 2024
- 10-QHCA
Oct 31, 2024
- 8-KHCA
Oct 25, 2024
- Q2 2024
- 8-KHCA
Aug 12, 2024
- 8-KHCA
Aug 8, 2024
- 10-QHCA
Jul 29, 2024
- 8-KHCA
Jul 23, 2024
- Q1 2024
- 10-QHCA
May 2, 2024
- 8-KHCA
Apr 30, 2024
- 8-KHCA
Apr 26, 2024
- Q4 2023
- 8-KHCA
Feb 26, 2024
- 8-K/AHCA
Feb 26, 2024
- 8-KHCA
Feb 23, 2024
- 8-KHCA
Feb 21, 2024
- 10-KHCA
Feb 16, 2024
- 8-KHCA
Jan 30, 2024
- Q3 2023
- 8-KHCA
Nov 9, 2023
- 10-QHCA
Oct 26, 2023
- 8-KHCA
Oct 24, 2023
- Q2 2023
- 10-QHCA
Aug 2, 2023
- 8-KHCA
Jul 27, 2023
- 8-KHCA
Jul 10, 2023
- Q1 2023
- 8-KHCA
May 26, 2023
- 8-KHCA
May 4, 2023
- 8-KHCA
May 2, 2023
- 10-QHCA
Apr 27, 2023
- 8-KHCA
Apr 21, 2023
- 8-KHCA
Apr 21, 2023
- 8-KHCA
Apr 6, 2023
- Q4 2022
- 10-KHCA
Feb 17, 2023
Earnings releases
17 documents- Q3 2026
- EX-99HCA
Oct 27, 2026
- Q2 2026
- EX-99HCA
Jul 24, 2026
- EX-99HCA
Jul 14, 2026
- Q1 2026
- EX-99HCA
Apr 24, 2026
- Q4 2025
- EX-99HCA
Jan 27, 2026
- Q3 2025
- EX-99HCA
Oct 24, 2025
- Q2 2025
- EX-99HCA
Jul 25, 2025
- Q1 2025
- EX-99HCA
Apr 25, 2025
- Q4 2024
- EX-99HCA
Feb 18, 2025
- EX-99HCA
Jan 24, 2025
- Q3 2024
- EX-99HCA
Oct 25, 2024
- Q2 2024
- EX-99HCA
Jul 23, 2024
- Q1 2024
- EX-99HCA
Apr 26, 2024
- Q4 2023
- EX-99HCA
Jan 30, 2024
- Q3 2023
- EX-99HCA
Oct 24, 2023
- Q2 2023
- EX-99HCA
Jul 27, 2023
- Q1 2023
- EX-99HCA
Apr 21, 2023
Presentations
0 documentsNo presentations for HCA Healthcare are held in this edition of the library.
Transcripts
0 documentsNo transcripts for HCA Healthcare are held in this edition of the library.
Mentioned by
3 companiesOther tracked companies whose held documents mention HCA Healthcare by name or ticker. A mention is counted once per document, from the document text the library holds.
“tors declared a quarterly cash dividend of $0.78 per share… …• Net income attributable to HCA Healthcare, Inc. increased 2.8 percent to $1.699 billion • Diluted earnings per share increased 11.6 percent to $7.62 per diluted share, and diluted earning”
“, remains unchanged. The Company’s guidance … …alternatives to net income attributable to HCA Healthcare, Inc. as a measure of operating performance or cash flows from operating, investing and financing activities as a measure of liquidity. Because n”
“…and HCA Healthcare's Sarah Cannon Research Institute and on November 1, 2022, McKesson completed the acquisition of Rx Savings Solutions. ◦ The US Oncology Network ”
See also the earnings calendar for every tracked company’s next earnings date.